Stocks in Focus on June 28: Railtel, Hindustan Copper, Dodla Dairy, Thyrocare to Lupin; here are the 5 Newsmakers of the Day

Domestic markets closed the lacklustre trade with decent gains on Friday, June 25, 2021. The S&P BSE Sensex gained 226.04 points or 0.43 per cent and closed at 52,925.04. The Nifty 50 index rose 69.90 points or 0.44 per cent to settle at 15,860.35. But certain stocks came in the news after the market was closed. These stocks can impact the indices, when it reopens on Monday, June 28, 2021. List of such five stocks:

See Zee Business Live TV Streaming Below:

Railtel + Hindustan Copper + Tamil Nadu Newsprint + Shree Renuka Sugars

Railtel Corp: The wholly-owned subsidiary of Indian Railways has reported a 17.4% YoY rise in the consolidated profit at Rs 27 crore for the quarter ended March 31, 2021. It had posted a profit of Rs 23 crore in the corresponding quarter of the previous financial year. The revenue from operations rose 9.3% YoY to Rs 429 crore in the reported quarter compared to Rs 392.6 crore posted last year. The EBITDA fell 32% YoY to Rs 72.5 crore against Rs 106.4 crore posted last year. The margin contracted to 17% in Q4FY21 compared to 27% posted in Q4FY20. Besides, the Board has recommended a final dividend of Rs 1.20 per share for the financial year 2020-21. This Final Dividend is in addition to an Interim Dividend of Rs 1 per share already paid by the Company for the financial year 2020-21.

Hindustan Copper:  The mining company has reported a consolidated loss of Rs 37 crore for the quarter ended March 31, 2021. It had posted a loss of Rs 514 crore in the corresponding quarter of the previous financial year. The revenue grew3.5 times to Rs 522 crore in the reported quarter compared to Rs 148 crore posted last year. The EBITDA stood at Rs 31 crore against the EBITDA loss of Rs 408 crore posted last year. 

Tamil Nadu Newsprint:  The Papermill company has reported a loss of Rs 3.93 crore for the quarter ended March 31, 2021. It had posted a profit of Rs 1.84 crore in the corresponding quarter of the previous financial year. The revenue from operations grew 24% YoY to Rs 1,124 crore in the reported quarter compared to Rs 901 crore posted last year. The EBITDA fell 27% to Rs 75.4 crore in the reported quarter compared to Rs 103 crore posted last year. The margins dropped to 6.7% in Q4FY21 compared to 11.4% posted in Q4FY20.

Shree Renuka Sugars: The sugar producer has reported a loss of Rs 44.9 crore for the quarter ended March 31, 2021. The company had posted a loss of Rs 145.2 crore in the corresponding quarter of the previous financial year. The revenue from operations fell 5% to Rs 1,299 crore in the reported quarter against Rs 1,374.8 crore posted last year. The EBITDA stood at Rs 229 crore up 25 times as against Rs 9.2 crore posted last year. The Margin grew 17.6% in Q4FY21 compared to 1% posted last year. 

2 Listings + IPO Closure

KIMS: Krishna Institute of Medical Sciences (KIMS Hospitals) will debut on the bourses today. The issue price for the IPO was Rs 825 per share. 

Dodla Dairy: Dodla Dairy will debut on the bourses today. The issue price for the IPO was Rs 428 per share. 

India Pesticides: Rs 800 crore initial public offering (IPO) of Pesticides India was subscribed 29.04 times on the last day of subscription. The RII was subscribed 11.3 times and the NII portion saw 51.88 times subscription. The price band of the issue has been fixed at Rs 290-296 per share. On the block are a fresh issue of up to Rs 100 crore and an offer for sale of up to Rs 700 crore worth of shares.

Thyrocare: Online drugstore PharmEasy PharmEasy will buy Thyrocare business. API Holdings Ltd., the parent of PharmEasy, has tied up with Thyrocare to buy the company. The agreement was signed through subsidiary Docon Technology. As per the agreement API Holdings will buy a 66.1% stake in Thyrocare for Rs 4,546 crore. It will buy an additional 26% stake through an open offer. The floor price has been fixed at Rs 1300/share (10.2% discount at CMP: Rs 1363). Together, the deal is valued at Rs 6,878 crore. The current market cap of the company is Rs 7,656 crores.

Lupin + Cadila 

Lupin: Global pharma major Lupin has announced the launch of Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 200 mg/300 mg, having received approval from the United States Food and Drug Administration (FDA). It is used in the treatment of HIV-1 infection. 
Cadila Healthcare: The COVID vaccine for children above 12 years is expected to arrive by August 2021. 

DCM Shriram + Rossell India + SBI Cards

DCM Shriram Industries: Abakkus Emerging Opportunities Fund bought 5.18 lakh shares at 361 per share. Finquest Financial Sold 2.38 lakh shares at 361 per share. Minal Bharat Patel Sold 3.97 lakh Shares at 361 per share. Ruchit Bharat Patel Sold 1.42 lakh Shares at 361 per share. 

Rossell India: Elara India Opportunities Fund sold 3.41 lakh shares (0.93%) at Rs 145.2 per share. 

SBI Cards and Payment Services:  Promoter SBI Life Insurance Company bought 13 lakh shares on June 24.